Past and future spread of the arbovirus vectors Aedes aegypti and Aedes albopictus
Boston Children's Hospital · Harvard University · +37 more institutions
Abstract
The global population at risk from mosquito-borne diseases-including dengue, yellow fever, chikungunya and Zika-is expanding in concert with changes in the distribution of two key vectors: Aedes aegypti and Aedes albopictus. The distribution of these species is largely driven by both human movement and the presence of suitable climate. Using statistical mapping techniques, we show that human movement patterns explain the spread of both species in Europe and the United States following their introduction. We find that the spread of Ae. aegypti is characterized by long distance importations, while Ae. albopictus has expanded more along the fringes of its distribution. We describe these processes and predict the…
Citation impact
- FWCI
- 135.27
- Percentile
- 100%
- References
- 72
Authors
41- MUMoritz U. G. KraemerCorresponding
Boston Children's Hospital, Harvard University, University of Oxford, Boston Children's Museum
- RCRobert C. Reiner
University of Washington, Institute for Health Metrics and Evaluation
- OJOliver J. Brady
London School of Hygiene & Tropical Medicine
- JPJane P. Messina
University of Oxford, Oxford Spires Academy
- MGMarius Gilbert
Université Libre de Bruxelles, Fund for Scientific Research
Topics & keywords
- Arbovirus
- Chikungunya
- Aedes aegypti
- Dengue fever
- Aedes albopictus
- Aedes
- Population
- Arbovirus Infections
- Sustainable cities and communities
Funding
- USUnited States Agency for International DevelopmentAwards: AID-OAA-A-14-00102, PREDICT-2
- BABill and Melinda Gates FoundationAwards: OPP1093011, OPP1106023, OPP1132415, OP1183567, 734584, OPP1159934
- WTWellcome TrustAwards: Z/17/Z, 206471/Z/17/Z
- ELEnhancing Learning and Research for Humanitarian Assistance
- EFEuropean Food Safety AuthorityAward: OC/EFSA/AHAW/2013/02
- ECEuropean CommissionAwards: 324247, 21893, 734584, 734548
- ECEuropean Centre for Disease Prevention and ControlAward: ECDC/09/018
- ANAgence Nationale de la RechercheAwards: 734548, 10-LABX-62-IBEID, ANR-16-CE35-0004, PIA/ANR-16-CONV-0005, ANR-16-CONV-0005, ANR-10-LABX-62-IBEID, ANR-10, grant ANR-10-LABX-62-IBEID, ANR-10-LABX-62
- NNNational Natural Science Foundation of ChinaAwards: 71690233, 91846301, 71771213, 71725001, 71522014, 71731009, 71790615
- ARAXA Research FundAwards: ANR-10-LABX-62-IBEID, PIA/ANR-16-CONV-0005
- ETEidgenössische Technische Hochschule Zürich
- NINational Institutes of HealthAwards: T32HD040128, R01LM011965, P01 AI098670, R01LM010812
- NINational Institute of General Medical Sciences
- NINational Institute of Allergy and Infectious DiseasesAwards: U10AI089674, P01 AI098670
- NINational Institute of Child Health and Human DevelopmentAward: T32HD040128
- UNU.S. National Library of MedicineAwards: R01LM010812, R01LM011965